Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.
about
Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.Human embryonic stem cells: a potential source for cellular therapy.Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant.Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction.
P2860
Q34583515-B9C65A0C-0948-4D4B-B454-8151CBB30B0DQ35661046-E749650A-F836-4685-9F40-C555A42A3E28Q36745425-FED3A6A9-742B-4104-83C5-FEBC592AB31DQ37034498-DC1EA73E-A085-4DF3-8318-82F562618B46Q37407845-1104E263-B990-4A21-ADD4-38C64F1BF185Q38586748-4DA83BF2-67E5-437C-B909-591A9DFBD8A9Q42234413-AE824955-8BF6-465C-B599-E60A3C52BFFFQ44402552-80B1CDBD-D411-4603-A2D5-9AEFDB6FBF3F
P2860
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Use of combination cytomegalov ...... multicenter, open-label study.
@en
Use of combination cytomegalov ...... multicenter, open-label study.
@nl
type
label
Use of combination cytomegalov ...... multicenter, open-label study.
@en
Use of combination cytomegalov ...... multicenter, open-label study.
@nl
prefLabel
Use of combination cytomegalov ...... multicenter, open-label study.
@en
Use of combination cytomegalov ...... multicenter, open-label study.
@nl
P2093
P1476
Use of combination cytomegalov ...... multicenter, open-label study
@en
P2093
B G Werner
E O'Rourke
M E Falagas
R Fairchild
R Ruthazer
P304
P356
10.1016/S0041-1345(01)02101-7
P407
P577
2001-06-01T00:00:00Z